ATLANTA, GA -- (MARKET WIRE) -- September 14, 2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the A.G. Edwards Emerging Growth Conference on Wednesday, September 20, 2006, at 8:30 a.m. ET at The New York Palace Hotel in New York, NY.
